Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
... in Shanghai, China announced today that Sundia has acquired Protein folding Shape Code (PFSC) technology for doing probe binding site for drug ... applied mathematics on this biology subject, generated a set of Protein folding Shape Code (PFSC) for a complete description of protein's complex 3D ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Canadian researchers discover gene related to the appearance of aging
... health benefits. However, proline is not completely understood. Researchers know that it helps make 'kinks' in protein chains, critical for correct folding of these proteins. But it seems to play an independent role in protection from cellular stress. Proline made internally in our bodies may have a ...Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...DNA Software, Inc. Honored as One of the 2009 "Michigan 50 Companies to Watch"
... and therapeutics. OMP™ (Oligonucleotide Modeling Platform™), the core engine that runs all of DNA Software's tools, models in silico the folding and hybridization of nucleic acids with exception accuracy. Visual OMP™ is a platform program for the design, simulation, and analysis of ...Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Announces Change to Board of Directors
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Could Database Software Help Cure Alzheimer's and Save the Earth?
... Parkinson's disease, emphysema and cystic fibrosis. Because experimental approaches provide only limited amounts of information about the actual folding process, Daggett Research Group employs computer simulations, which generate massive amounts of data that must be analyzed. The lab has already ...Amicus Therapeutics Announces Third Quarter 2008 Financial Results
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Opens Research Facility in San Diego
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amarin Announces Completion of the First Tranche of $60 Million Private Placement
... 1995. Dr. Gordon received a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology. His doctoral work involved studies of protein folding and assembly. He received a Bachelors degree from Harvard College. Dr. Eric Aguiar is a Partner at Thomas, McNerney & Partners. He has 16 years of ...Amicus Therapeutics Announces First Quarter 2008 Financial Results
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Foldable and stretchable, silicon circuits conform to many shapes
... circuit that can wrap around complex shapes such as spheres, body parts and aircraft wings, and can operate during stretching, compressing, folding and other types of extreme mechanical deformations, without a reduction in electrical performance. The notion that silicon cannot be used in such ...Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...Amicus Therapeutics to Host R&D Day
... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...